Mr. Craig Milne reports

INNOVOTECH INC. ANNOUNCES ANNUAL GENERAL AND SPECIAL MEETING RESULTS, NEW DIRECTOR AND CORPORATE CHANGES

Innovotech Inc. concluded its annual general and special meeting of shareholders on July 8, 2025. Shareholders voted in favour of all matters, which included the re-election of James Timourian, Karen Farkas, David Tam, Julie Wright, Brad Clark and Craig Milne as directors of the company. Shareholders approved the appointment of D&H Group LLP as the company auditor for the next fiscal year and continued the omnibus security based compensation plan first adopted in 2024.

Innovotech also welcomes Arden Tse to the board of directors. Mr. Tse is an Edmonton-based venture capital investor with over 20 years of diverse investment management experience. He currently leads Yaletown Partners' early-stage technology investments in Alberta through the Accelerate Funds II to IV, and he specializes in identifying high-potential start-ups in life sciences and technology. Mr. Tse holds a BSc and an MBA in finance from the University of Alberta, and is a certified executive coach through Royal Roads University.

In addition, Innovotech announces the departure of two long-serving executives, chief operating officer Dr. Tyler Boone and chief scientific officer Dr. Patricia Nadworny.

"We thank each of them for their long-term dedicated service and accomplishments over the years with Innovotech," said Craig Milne, chief executive officer.

About Innovotech Inc.

Innovotech is a diversified Canadian technology company with business operations in a growing portfolio of specialized laboratory services, biotechnology businesses and proprietary intellectual property. Innovotech manages several subsidiary companies. Innovotech Labs Corp. is a contract research organization that owns and provides proprietary devices for anti-microbial testing in multiple applications and commercializes anti-microbial silver solutions. Keystone Labs Inc. is a DEL-accredited lab serving the Canadian pharmaceutical industry and industrial markets. Innovotech owns a 60-per-cent stake in NouLifeSciences Inc., a company holding intellectual property related to anti-oxidant molecules with potential applications in cosmetics and various medical conditions including neuropathies.

We seek Safe Harbor.